ADC-205

多替拉韦拉米夫定替诺福韦三联片

Report date: 2026/01/19 11:22:11

Base Information

Drug NameADC-205
Drug Alias NameDolutegravir/Lamivudine/Tenofovir多替拉韦/拉米夫定/替诺福韦ADC-205ADC205
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHIV integrase inhibitorsReverse transcriptase inhibitors
TargetsHIV integraseReverse transcriptase
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJiangsu Aidea Pharmaceutical Group Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Aidea Pharmaceutical Group Co Ltd
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A